News Headlines

  1. Nordic Capital To Partner With Minerva Imaging, To Support Its Growth Journey In The Radiopharmaceutical Space 6/10/2025

    The investment will be made in close partnership with the founders of Minerva, marking a joint commitment to seek to accelerate the company's growth, international expansion and further strengthening its integrated platform and service offerings, with the ambition of building a global market-leading radiopharmaceutical platform.

  2. Axio BioPharma And Likarda Announce Strategic Partnership To Accelerate Biologic Drug Development And Delivery 6/9/2025

    Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation technologies, today announced a strategic partnership to accelerate innovation in biologic drug development.

  3. Glycovax Pharma Commercializes A More Affordable CRM197 Protein 6/9/2025

    Glycovax Pharma Inc. has begun large-scale biomanufacturing of the CRM197 protein for use in numerous conjugate vaccines for human and animal vaccines.

  4. University Of Oxford And ReciBioPharm Expand Strategic Collaboration In Fight Against Malaria 6/9/2025

    The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division and a leading Contract Development and Manufacturing Organisation (CDMO), are expanding their long-standing collaboration with the development of two blood-stage malaria vaccine candidates for Phase 1/2 clinical trials.

  5. Wuxi Biologics Kicks Off Construction Of Microbial Manufacturing Site For Commercial Production In Chengdu 6/9/2025

    WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has kicked off construction of its new microbial manufacturing site for commercial production in the Wenjiang district of Chengdu, a renowned, vibrant hub for pharmaceutical development.

  6. GL CHEMTEC Announces Completion Of A New GMP Facility For Advanced Pharmaceutical Materials 6/9/2025

    GL CHEMTEC, a leading North American-based CDMO providing advanced chemistry services to the pharmaceutical and biotech sectors, is pleased to announce the completion of our state-of-the-art Good Manufacturing Practice (GMP) Kilo lab facility.

  7. bitBiome Announces Strategic Partnership With Leading CMO For Manufacturing And Supply Of Products 6/5/2025

    bitBiome, Inc., a biotechnology company unlocking the potential of our planet's microbes to power the future of the bioeconomy, today announced a new partnership that will enable large-scale enzyme, protein and ingredient manufacture.

  8. Veeva and Sarah Cannon Research Institute Form Strategic Collaboration To Advance Oncology Clinical Trials 6/4/2025

    Veeva Systems (NYSE: VEEV) and Sarah Cannon Research Institute (SCRI) today announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI's more than 200 research site locations. SCRI is adopting Veeva Clinical Platform to unify its contract research organization (CRO) and site management organization (SMO) on a single platform for seamless data flow across clinical teams and research sites.

  9. Aizon And Sequence Announce Strategic Partnership To Transform Biopharmaceutical Manufacturing With AI-Powered Solutions 6/4/2025

     Aizon and Sequence are pleased to announce a new strategic partnership aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry. This collaboration will combine Aizon's cutting-edge AI and data analytics platform with Sequence's engineering and compliance expertise to deliver intelligent, compliant, and manufacturing-centric solutions that accelerate digital transformation in regulated environments.

  10. ASP Isotopes And Isotopia Announce Supply Agreement For Gadolinium-160 To Accelerate Terbium-161 Production For Advanced Cancer Therapies 6/4/2025

    ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it has recently entered into a supply agreement with Isotopia Molecular Imaging Ltd. related to the supply of enriched Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical isotope with significant potential in targeted radiotherapeutics.